About 3 results found for searched term "CDDO-EA" (0.122 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M14592 | CDDO-EA | Keap1-Nrf2 |
| CDDO ethyl amide; TP319; RTA 405 | ||
| CDDO-EA is an NF-E2 related factor 2/antioxidant response element (Nrf2/ARE) activator. | ||
| M21470 | CDDO-dhTFEA | NF-κB |
| RTA dh404 | ||
| CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound that effectively activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB. | ||
| M58515 | CDDO-TFEA | Keap1-Nrf2 |
| CDDO-Trifluoethyl amide; RTA 404; TP-500 | ||
| CDDO-TFEA (RTA 404; TP-500) is a trifluoroacetamide derivative of CDDO with enhanced ability to cross the blood-brain barrier. CDDO is an Nrf2 activator that inhibits proliferation and induces differentiation and apoptosis in various cancer cells. CDDO-TFEA can enhance Nrf2 expression and signaling in various neurodegenerative disease models. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
